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Abstract Deoxyhypusine synthase is essentially required for the 
post-translational formation of hypnsine, a modification of a spe- 
cific lysine residue in eukaryotic initiation factor 5A, which ap- 
pears to be pivotal for cell proliferation. From a human peripheral 
blood mononuclear cells cDNA library we isolated two independ- 
ent sequences encoding biologically active deoxyhypusine syn- 
thase. DNA sequence analysis revealed a 369 amino acid protein 
with a molecular mass of 41.055 kDa. This recombinant de- 
oxyhypusine synthase showed significant catalytic activity in syn- 
thesis of deoxyhypusine after in vitro transcription and transla- 
tion as well as upon expression in Escherichia coil Using a panel 
of somatic rodent-human cell hybrids we localized the de- 
oxyhupusine synthase gene to human chromosome 19. 
Key words." Eukaryotic initiation factor 5A; Hypusine 
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1. Introduction 
The eukaryotic initiation factor 5A (eIF-5A) is the only 
known cellular protein with a unique hypusine modification 
(for reviews, see [9,10]). This spermidine-dependent posttrans- 
lational modification occurs at the Lys-50 residue of eIF-5A in 
two enzyme-catalyzed reactions, which involve the transfer of 
the aminobutyl moiety of spermidine to the e-amino group of 
Lys-50 and subsequent hydroxylation of this intermediate. The 
hypusine modification appears to be required for biological 
elF-5A activity. 
It has been suggested that eIF-5A plays a role in the initiation 
of protein synthesis [9,10]. However, more recent data showed 
that initiation of protein synthesis in eIF-5A-depleted yeast 
cells is not significantly affected, indicating that eIF-5A might 
have essential activities in addition to, or instead of, translation 
initiation [4]. Interestingly, eIF-5A has recently been identified 
as a cellular cofactor critically required for the activity of  HIV-1 
regulatory protein Rev [1 1], which plays a key role in the com- 
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plex regulation of HIV-1 gene expression and thus, in the gen- 
eration of infectious virus particles [1]. 
Deoxyhypusine synthase catalyzes the first step in the hypu- 
sine formation on eIF-5A, whereas the second step is mediated 
by deoxyhypusine hydroxylase. Recently, we described the pu- 
rification and characterization of the human deoxyhypusine 
synthase from HeLa cells on protein level [6]. 
Here we report the molecular cloning of the corresponding 
cDNA and the expression of active recombinant human de- 
oxyhypusine synthase. Furthermore, we have localized the gene 
for the human deoxyhypusine synthase to chromosome 19. 
2. Materials and methods 
2.1. Generation of human deoxyhypusine ~wnthuse-specific PCR 
products 
Total RNA was isolated from human HeLa cells using guanidinium 
thiocyanate extraction and CsCI gradient centrifugation [8]. Ten,ug of 
total HeLa RNA was used for first strand cDNA synthesis (Amersham, 
Aylesbury, Bucks, UK). One-tenth of this reaction mixture was subse- 
quently used for PCR amplification. The sequence of the synthetic 
primers used to amplify partial human deoxyhypusine synthase tran- 
scripts were deduced from primary peptide sequences derived from the 
human deoxyhypusine synthase isolated from HeLa cells [6]. The PCR 
primers were designed according to the human codon usage bias [7]. 
The following PCR primers were generated: sense 5'-AAGATGA- 
TTGCCCGGCTGGGCAAGGAGATCAAC-Y (from the peptide se- 
quence KMIARLGKEIN), and antisense: 5'-GAGGTTGGCATTG- 
GCAATGTGGTGCTT (from the peptide sequence KHHIANANL; 
[6]). Twenty-five cycles of amplification (30 s at 94°C, 30 s at 55°C and 
30 s at 72°C) were performed in a 100/,tl reaction mixture (10 mM 
Tris-HC1 buffer, pH 8.3, containing 50 mM KC1, 1.5 mM MgCI2, 0.01% 
gelatin, 200]1M dNTP, 1 ~uM sense primer, 1 ~uM antisense primer and 
3 units of Taq polymerase (Perkin-Elmer)) covered with 100 /11 of 
paraffin. A 273 bp fragment specific for the human deoxyhypusine 
synthase was amplified, and the correct deoxyhypusine synthase nucle- 
otide sequence has been confirmed by DNA sequence analysis (Se- 
quenase 2.0; United States Biochemicals Corp., Cleveland, OH). 
2.2. Isolation of human deoxyhypusine synthase and cDNA sequencing 
2 x 105 independent colonies of a phytohemagglutinin stimulated 
human peripheral blood mononuclear cells cDNA library cloned into 
the 2-GT10 vector were screened with the [~-32p]-labeled 273 bp PCR 
product of human deoxyhypusine synthase. After hybridization, posi- 
tive clones were sequenced using a Sequenase kit. 
2.3. Functional expression of in vitro transcribed~translated 
deoxyhypusine synthase 
Sequences ncoding human deoxyhypusine synthase, or the antisense 
strand of human deoxyhypusine synthase cDNA, were cloned into the 
EcoRI site of the pcDNA3 vector (Invitrogen Corp., San Diego, CA) 
to generate the plasmids pSyns and pSynas used for in vitro transcrip- 
tion with T7 polymerase. One,ug of either pSyns or pSynas were in vitro 
transcribed and translated using the TNT system (Promega, Madison, 
WI) with either [35S]cysteine (Amersham) or non-radioactive cysteine. 
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The radioactive labeled human deoxyhypusine synthase was resolved 
using 12% SDS-polyacrylamide g l electrophoresis and visualized by 
autoradiography. 
2.4. Recombinant protein expression 
The full-length coding region for the human deoxyhypusine synthase 
was amplified by PCR using the cDNA clone described in this paper 
as template with the intoduction of a NcoI site at the 5' end and a 
BamHI site at the 3' end (sense oligonucleotide: 5'-GGGAAT- 
TCCATATGGAAGGTTCCCTGGAACGG; antisense oligonucleo- 
tide: 5'CGCGGATCCGCTCAGTCCTCGTTCTTCTCATGC). After 
amplification, the PCR product was digested with Ncol and BamHl, 
subcloned into the expression vector pET-1 la [12] and transformed inlo 
the E. coli strain BL2 I(DE3). An overnight bacterial culture was diluted 
1 : 10 in fresh LB-medium (supplemented with 100#g/ml ampicillin) and 
grown for 1 h at 37°C. Subsequently, IPTG was added (0.5 mM) and 
culture proceeded for a further 4 h. The cells were pelletted and resus- 
pended in 2 ml of PBS containing 1mM DTT. After sonication (twice 
for 30 s at a setting of 10 W) the lysate was centrifuged for 2 min at 
14,000 rpm in an Eppendorf centrifuge and the pellet dissolved in 1 ml 
of 8 M urea in H20 and dialysed overnight against 0.3 M glycine 
NaOH (pH 9.0)10.1% Tween 20. After an additional centrifugation step 
(2 min at 14,000 rpm) the supernatant was analysed for deoxyhypusine 
synthase activity. 
2.5. Deoxyhypusine synthase assay 
2.5.1. Small-scale gel filtration assay. The deoxyhypusine synthase 
activity assay is based on the incorporation of radioactivity which is 
transferred from [3H]spermidine to the eIF-5A precursor protein [6]. 
Briefly, the standard reaction mixture contained 6#M [3H]spermidine 
(previously diluted with non-radioactive spermidine to a specific activ- 
ity of 360 mCi/mmol), 1 mM NAD ÷, 2 #M recombinant eIF-5A precu r- 
sor protein (prepared according to [2]) and various amounts of the 
recombinant human deoxyhypusine synthase in 0.3 glycin~NaOH 
buffer, pH 9.0, containing 1 mM DTT. Following an incubation for 
2 h at 37°C, 300 #1 aliquots of the reaction mixture were passed over 
Sephadex G-25 gel filtration columns (PD-10 columns, Pharmacia, 
Uppsala, Sweden) in order to separate the labeled eIF-5A from excess 
spermidine. The incorporated radioactivity was measured in a liquid 
scintillation counter. [3H]Spermidine-HC1 was obtained from DuPont- 
NEN (Dreieich, Germany); the unlabeled spermidine from Calbio- 
chem, and NAD ÷ from Boehringer-Mannheim (Germany). 
2.5.2. Nitrocellulose membrane assay. The standard enzymatic 
reaction mixture (total volume 200 #1) contained 5#g elF-5A, 0.5 ,uCi 
[3H]spermidine (15 Ci/mmol), 1 mM NAD +, 1 mM DTT and various 
quantities of the recombinant human deoxyhypusine synthase in 0.3 M 
glycine-NaOH buffer, pH 9.0, supplemented with 50 ,ug/ml BSA. The 
mixture was incubated at 37°C for 3 h and stopped by adding 100 #1 
of 20 mM spermidine inPBS. The reaction mixture was then transferred 
onto a nitrocellulose membrane (Millipore HAWPO2500), which was 
pre-soaked in 20 mM spermidine/PBS for 30 min, and filtered by apply- 
ing vacuum using a ten-place filter manifold (Hoefer). After washing 
with 10 ml, PBS filters were dried for 30 min at 45°C and measured in 
a liquid scintillation counter. 
2.6. RT-PCR and Southern blot 
cDNAs generated from HeLa, HMC-1 (mast cell), U937 (monocytic 
cell), MM6 (monocytic ell), HUT78 (T cell), Jurkat (T cell) and MT4 
(T cell) cell lines were amplified by PCR using Taq polymerase (Perkin- 
Elmer). Following oligonucleotide primer pairs were used: human de- 
oxyhypusine synthase (sense 5'-ATGGAAGGTTCCCTGGAACGG; 
antisense 5'-GGATGTGGTTCTTCTGGGCC) generating a 688 bp 
product; human S14 ribosomal protein (sense 5'-GGCAGACCGAG- 
ATGAATCCTCA; antisense 5'-CAGGTCCAGGGGTCTTGGTCC) 
amplifying an internal 143 bp control product. An aliquot of the PCR 
products were size-fractionated on a 1% agarose gels, transferred to 
Hybond-N filters (Amersham) and hybridized with oligonucleotides 
specific for human deoxyhypusine synthase (5'-CTGCTCCATCACC- 
ATCTGATCCAG) and human Sl4 (5'-CAGGTCCAGGGGTCT- 
TGGTCC). These probes were 3'end labeled using a terminal trans- 
ferase kit (Boehringer) and [~-nP]dATP prior to hybridization. 
2. 7. Chromosomal localization 
For the chromosomal localization of the human deoxyhypusine syn- 
thase gene, we used NIGMS mapping panel 2, obtained from Coriell 
Institute for Medical Research (Camden, N J), in combination with 
Southern blot analysis of restriction enzyme digested hybrid DNAs. 
DNA (3 ,ug) from each hybrid as well as from the parental human, 
murine, and hamster cell lines was digested with the restriction enzyme 
NcoI, separated on a 0.7% (w/v) agarose gel and blotted onto Hybond- 
N filters (Amersham) in20 x SSC. Filters were then hybridized with the 
[~-32p]dATP radiolabelled 273 bp fragment specific for the human de- 
oxyhypusine synthase. After washing, the filters were analysed using a 
phosphor-imager. 
3. Results and discussion 
RT-PCR was used to generate a deoxyhypusine synthase 
specific fragment from HeLa ceils. A single 273 bp product was 
obtained by using synthetic oligonucleotide primers, and this 
fragment was subsequently used to screen a phytohemag- 
glutinin stimulated human peripheral blood mononuclear  cell 
cDNA library. Two positive clones were isolated. The complete 
nucleotide and deduced amino acid sequence of clone, pdSyn-1, 
is depicted in Fig. 1. This clone encodes the complete protein 
sequence (369 amino acids) of the mature human deoxyhypu- 
sine synthase. The eDNA insert contains 84 bp of the 5' un- 
10 30 50 
GGCGCGTCGGGGTTT~CGCGTTTCTGGGCCGCCGT~GCCCGGCCTAGGGGCAGCTTTG 
70 90 Ii0 
ACTCGAGAGCCGGCTATAGGCGCATGG~GGTTCCCTGG~CGGGAGGCGCCACGGGGGG 
M E G S L E R E A P R G A  
130 150 170 
CGCTGGCCGCCGTGCTAAAGCACAGCTCGACCTTGCCGCCCGAAAGCACCCAGGTCCGGG 
L A A V L K H S S T L P P E S T Q V R G  
190 210 230 
GCTACGACTTC~CCGCGGTGTG~ACCGCGCACTGCTGGAGGCC~CGGCACCACCG 
Y D F N R G V N Y R A L L E A F G T T G  
250 270 290 
GCTTCC~GC~CC~C~C~GCGC~TGTACAGC~GTC~TGCCATGATCGAG~GA 
F Q A T N F G R A V Q Q V N A M I E K K  
310 330 350 
AGCTGG~CCACTGTCACA~ATG~GACCA~ACGCGGACCTGACCCAGA~CGCCGCC 
L E P L S Q D E D Q H A D L T Q S R R P  
370 390 410 
CAC~ACCA~TGCACCA~CCTGGGATATACATCC~CCTCA~AGTTCAGGCA~C 
L T S C T I F L G Y T S N L I S S G I R  
430 450 470 
GTGAGACCA~CGCTACCTTGT~AGCAC~CATGGTGGACGTATTG~GACCACA~TG 
E T I R Y L V Q H N M V D V L V T T A G  
490 510 530 
GCGCg~GT~AGG~GACCTCATC~GT~CTGGC~CCACATAC~GCGAGT~A~C 
G V E E D L I K C L A P T Y L G E F S L  
550 570 590 
TCAGGG~A~CGGGAG~C~GATC~TA~ATCGGAAACCT~TGGTGCCCA 
R G K E L R E N G I N R I G N L L V P N  
610 630 650 
ATGAG~TTAC~C~GT~GAGGACTGGCTGAT~CCA~CT~ATCAGAT~TGATGG 
E N Y C K F E D W L M P I L D Q M V M E  
670 690 710 
AGCAG~CACAGA~GTGTAAAGTGGAC~CTTCT~GATGATC~CCGGCTGGGC~GG 
Q N T E G V K W T P S K M I A R L G K E  
730 750 770 
AGATC~C~CCCAGAG~CGTGTATTACTG~CCCAG~G~CCACATCCCTG~T~A 
I N N P E S V Y Y W A Q K N H I P V F S  
790 810 830 
GTCCC~AC~ACAGAC~CTC~T~GCGACATGATCTTC~CCA~CCTAC~G~CC 
P A L T D G S L G D M I F F H S Y K N P  
850 870 890 
CGG~CT~TCCT~ACATCGTTGAGGACCTGA~CTCATC~CACACAGGCCATCT~G 
G L V L D I V E D L R L I N T Q A I F A  
910 930 950 
CC~GTGCA~GGGATGA~A~CT~GC~CG~GTGGTG~GCACCACA~C~TG 
K C T G M I I L G G G V V K H H I A N A  
970 990 1010 
CC~CCTCAT~CGGGGCCGACTACGCTGTTTACAT~CAeAGCCCAGGAG~TG 
N L M R N G A D Y A V Y I N T A Q E F D  
1030 1050 1070 
ATGGCTCTGACTCAGGTGCCCGACCAGACGAG~TGTCTCCTG~GC~GATCC~GT~ 
G S D S G A R P D E A V S W G K I R V D  
1090 1110 1130 
ATGCACAGCCCGTC~TCTATGCTGACGCCTCCCTGGTCTTCCCCCTGCTT~GGCTG 
A Q P V K V Y A D A S L V F P L L V A E  
1150 1170 1190 
AAACC~TGCCCAG~GATGGATGCCTTCATGCATGAG~G~CGAGGACTGAGCGGCTG 
T F A Q K M D A F M H E K N E D *  
1210 1230 1250 
CGTCCCAGG~GGTCTTACCCCCTCTTCTATTTATT~TTTGCAGACCCAGCCCCTCCCC 
1270 1290 1310 
TACTTTTTGGTCAGCTACGTCTCTAG~T~GATGGTATCTG~GTCAA~ 
Fig. 1. Nucleotide and predicted amino acid sequence of the eDNA 
clone pdSyn-I encoding human deoxyhypusine synthase. The deduced 
amino acid sequence is shown below the nucleotide sequence. The 
putative polyadenylation signal is underlined. 
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translated region and a l l4  bp long 3' untranslated region 
followed by a poly(A) tail. The 3' untranslated region contains 
a putative polyadenylation signal (AATAA) 93 bp downstream 
from the stop codon. Comparison of the published protein 
sequence of the yeast deoxyhypusine synthase [5] with the de- 
duced amino acid sequence from clone pdSyn-1 revealed nearly 
60% identity, indicating that the human deoxy-hypusine syn- 
thase may have functional similarity with the enzyme present 
in yeast. 
The cell specific synthesis of human deoxyhypusine synthase 
in a number of human cell lines was investigated by RT-PCR 
using cDNAs generated from HeLa, HMC-1, U937, MM6, 
HUT78, Jurkat and MT4 cells. Using PCR primers pecific for 
the human deoxyhypusine synthase a product of 688 bp was 
amplified from all cell lines (Fig. 2). In order to show the 
specificity of these amplification products, the DNA was blot- 
ted and hybridized with an internal, deoxyhypusine synthase 
specific oligonucleotide. A specific signal was identified in each 
of the tested cell lines. The highest ranscription rate was iden- 
tified in HMC-I,  U937 and MM6 cells. 
Coupled in vitro transcription/translation of the human de- 
oxyhypusine synthase cDNA in presence of [35S]cysteine re- 
sulted in the synthesis of a radiolabeled protein of the expected 
molecular mass of approx. 41 kDa (Fig. 3A, lane 2). In addi- 
tion, two signals corresponding to proteins of lower molecular 
mass were also detectable. These translation products presum- 
ably originate from the usage of internal Met-codons within the 
deoxyhypusine synthase coding region. In contrast, no signal 
was detectable when the corresponding control antisense 
sequences were transcribed in this in vitro reaction (Fig. 3A, 
lane 1). 
The reticulocyte xtract containing the in vitro translated 
recombinant human deoxyhypusine synthase possessed e- 
oxyhypusine synthase activity. As shown in Fig. 3B, this activ- 
ity was dose dependent and reaching a distinct maximum value. 
In sharp contrast, the reticulocyte extract carrying the human 
deoxyhypusine synthase antisense construct did not show any 
significant deoxyhypusine synthase activity. 
Human deoxyhypusine synthase was also expressed as a re- 
combinant protein in E. coli using the expression vector pET11- 
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Fig. 2. RT-PCR of total RNA from different human cell lines. 
(A) Amplified bands were hybridized with a human deoxyhypusine 
synthase specific oligonucleotide as described in section 2. (B) As an 
internal oading control, the same blot was also hybridized with an 
oligonucleotide specific for the human S14 ribosomal protein. 
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Fig. 3. (A) Autoradiography of  reticulocyte extracts expressing anti- 
sense (lane l) or sense (lane 2) human deoxyhypusine synthase se- 
quences. The reaction products were separated on 12% SDS-PAGE. 
The triangle indicates the position of the deoxyhypusine synthase. 
(B) Biological activity of sense (circles) and antisense (triangles) se- 
quences of human deoxyhypusine synthase after coupled in vitro tran- 
scription and translation. 
a, as shown in Fig. 4. The recombinant deoxyhypusine syn- 
thase, which was prepared from the pellet fraction was >90% 
pure as judged by 2D gel electrophoresis and subsequent s ain- 
ing with siver nitrate and shows an approx, molecular weight 
of 41 kDa (not shown). A specific activity of 30,000 units/mg 
of protein was determined for the recombinant human de- 
oxyhypusine synthase using the small-scale gel filtration assay 
(one unit is defined as the amount of enzyme forming 1 pmol 
of product in 2 h at 37°C). 
In order to determine the chromosomal localization of the 
human deoxyhypusine synthase gene, we used a human-rodent 
somatic cell hybrid mapping panel consisting of 24 single 
human chromosome hybrids. The parental human, hamster 
and murine cell lines were digested with the restriction enzyme 
NcoI. After hybridization with the [czJ2P]-labeled 273 bp PCR 
product of human deoxyhypusine synthase, a unique NcoI re- 
striction band was identified for the human specific deoxyhypu- 
198 D. Bevec et al./FEBS Letters 378 (1996) 195-198 
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Fig. 4. Recombinant expression of the deoxyhypusine synthase in 
E. coli. Lane 1 shows non-induced bacterial cell lysates. Lane 2 repre- 
sents the total cell lysate after 4 h induction with IPTG. The arrow 
indicates the position of the recombinant deoxyhypusine synthase. 
sine synthase. This NcoI fragment was clearly distinguishable 
from the hamster and mouse hybridization signals (data not 
shown). Using the human-rodent mapping panel this human 
specific Ncol-fragment was only detected in the somatic cell 
hybrid containing chromosome 19. 
The cloning of an active human deoxyhypusine synthase will 
allow to perform functional as well as structural studies in order 
to elucidate the mechanism of deoxyhypusine synthesis, and in 
addition to generate possible inhibitors which could be ex- 
ploited for the regulation of cell proliferation. Furthermore, the 
knowledge of the chromosomal localization of the gene coding 
for the human deoxyhypusine synthase provides a potentially 
valuable genetic marker, which may be useful for genetic link- 
age studies. 
At the final stage of the completion of this work, another 
group reported the cDNA cloning of the human deoxyhypusine 
synthase from the HeLa cell line, showing one amino acid 
exchange at position 11 [3]. The here-described clone codes for 
CGG (Arg) at this position, whereas the HeLa sequence n- 
codes GCG (Ala). 
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